FDA Device recall Z-0734-2022
Azurion systems with software release R2.0.x
- FDA Device
- Class II
- completed
- Published 2022-03-30
On 2022-03-30 the FDA classified a Class II recall of Azurion systems with software release R2.0.x by Philips Healthcare, citing in the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is select….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0734-2022 |
| Classification | Class II |
| Status | completed |
| Initiated | 2021-05-26 |
| Published | 2022-03-30 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Philips Healthcare |
| Distribution | US |
Product
Azurion systems with software release R2.0.x
Reason
In the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a software defect, when the study is initiated by pressing Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.
Identifiers
| code_info | Model(s) Azurion R2.1 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0734-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.